Long S, Wang Y
Turk J Obstet Gynecol. 2025; 22(1):1-12.
PMID: 40062608
PMC: 11894771.
DOI: 10.4274/tjod.galenos.2025.24983.
Li X, Wang H, Wang T, Cui H, Wu L, Wang W
BMC Womens Health. 2024; 24(1):539.
PMID: 39334255
PMC: 11429476.
DOI: 10.1186/s12905-024-03374-8.
Mobinikhaledi M, Faridzadeh A, Farkhondeh T, Pourhanifeh M, Samarghandian S
Curr Mol Med. 2024; 24(10):1269-1281.
PMID: 39300715
DOI: 10.2174/0115665240263059231002093454.
Arab M, Jafari Ashtiani A, Ghavami B, Nouri B, Noghabaei G, Raoufi M
J Family Reprod Health. 2024; 18(2):140-145.
PMID: 39011410
PMC: 11246739.
DOI: 10.18502/jfrh.v18i2.15938.
Kayahashi K, Hasan M, Khatun A, Kohno S, Terakawa J, Horike S
Commun Biol. 2024; 7(1):740.
PMID: 38890503
PMC: 11189448.
DOI: 10.1038/s42003-024-06433-w.
Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.
Agusti N, Kanbergs A, Nitecki R
Gynecol Oncol. 2024; 185:121-127.
PMID: 38402734
PMC: 11275632.
DOI: 10.1016/j.ygyno.2024.02.020.
Multi-parametric MRI-based radiomics for preoperative prediction of multiple biological characteristics in endometrial cancer.
Ma C, Zhao Y, Song Q, Meng X, Xu Q, Tian S
Front Oncol. 2024; 13:1280022.
PMID: 38188296
PMC: 10768555.
DOI: 10.3389/fonc.2023.1280022.
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
Spencer N, Sanchez A, Gopalam R, Subbarayalu P, Medina D, Yang X
Int J Mol Sci. 2023; 24(24).
PMID: 38139260
PMC: 10744027.
DOI: 10.3390/ijms242417426.
Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines.
Rickard B, Overchuk M, Tulino J, Tan X, Ligler F, Bae-Jump V
Environ Health. 2023; 22(1):87.
PMID: 38098045
PMC: 10720226.
DOI: 10.1186/s12940-023-01034-2.
Gene and Protein Expression in Endometrial Cancer and Its Significance.
Kiewisz J, Wasniewski T, Kiezun J, Skowronska A, Kaczmarek M, Szostak B
Cancers (Basel). 2023; 15(19).
PMID: 37835474
PMC: 10571897.
DOI: 10.3390/cancers15194780.
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience.
Tuninetti V, Pace L, Ghisoni E, Quara V, Arezzo F, Palicelli A
Cancers (Basel). 2023; 15(14).
PMID: 37509300
PMC: 10377998.
DOI: 10.3390/cancers15143639.
Cell division cycle associated 8 promotes the growth and inhibits the apoptosis of endometrial cancer cells by regulating cell cycle and P53/Rb signaling pathway.
Li W, Qin Y, Chen X, Wang X
Am J Transl Res. 2023; 15(6):3864-3881.
PMID: 37434858
PMC: 10331643.
Natural products modulate cell apoptosis: a promising way for treating endometrial cancer.
Zhou X, Zeng Y, Zheng R, Wang Y, Li T, Song S
Front Pharmacol. 2023; 14:1209412.
PMID: 37361222
PMC: 10285317.
DOI: 10.3389/fphar.2023.1209412.
Conservative treatment of endometrial cancer in women of reproductive age (Review).
Bourou M, Matsas A, Vrekoussis T, Mastorakos G, Valsamakis G, Panoskaltsis T
Mol Clin Oncol. 2023; 19(1):55.
PMID: 37323245
PMC: 10265581.
DOI: 10.3892/mco.2023.2651.
MicroRNA-372 acts as a double-edged sword in human cancers.
Tajik F, Alian F, Yousefi M, Azadfallah A, Hoseini A, Mohammadi F
Heliyon. 2023; 9(5):e15991.
PMID: 37251909
PMC: 10208947.
DOI: 10.1016/j.heliyon.2023.e15991.
PIK3CA mutation in endometriotic epithelial cells promotes viperin-dependent inflammatory response to insulin.
Wilson M, Harkins S, Reske J, Siwicki R, Adams M, Bae-Jump V
Reprod Biol Endocrinol. 2023; 21(1):43.
PMID: 37170094
PMC: 10173629.
DOI: 10.1186/s12958-023-01094-6.
lncRNA XIST/miR‑129‑2‑3p axis targets CCP110 to regulate the proliferation, invasion and migration of endometrial cancer cells.
Chen S, Liang Y, Shen Y, Wang X
Exp Ther Med. 2023; 25(4):159.
PMID: 36911384
PMC: 9996364.
DOI: 10.3892/etm.2023.11858.
UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling.
Zhang P, Guo H, Zhao F, Jia K, Yang F, Liu X
Open Med (Wars). 2023; 18(1):20220567.
PMID: 36852267
PMC: 9961967.
DOI: 10.1515/med-2022-0567.
Ferroptosis-related lncRNA model based on CFAP58-DT for predicting prognosis and immunocytes infiltration in endometrial cancer.
Qin A, Qian Q, Cui X, Bai W
Ann Transl Med. 2023; 11(3):151.
PMID: 36846008
PMC: 9951017.
DOI: 10.21037/atm-22-6659.
Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition.
Yammine S, Huybrechts I, Biessy C, Dossus L, Panico S, Sanchez M
BMC Cancer. 2023; 23(1):159.
PMID: 36797668
PMC: 9936701.
DOI: 10.1186/s12885-023-10611-0.